Centers for Disease Control awards contract to Kephera Diagnostics for point-of-care test for Taeniasis
Framingham, MA – November 13, 2018. Kephera Diagnostics has won a $150,000 Phase I SBIR contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a point-of-care test for Taeniasis, the company announced today. The Phase I contract will support the generation of key immunological reagents with which the test will be…